Who are the AACR Scientific Achievement Award winners?
Drug Discovery World
APRIL 14, 2023
Schreiber’s award lecture will be held on Monday April 17 at 5:30pm ET.
DNA Immune Response Magazine 
130 
Scaling Phage Therapy
Codon
FEBRUARY 13, 2024
doi: 10.2210/rcsb_pdb/goodsell-gallery-048 The Virus that Cures It’s been over 25 years since the science magazine Discover first ran an extraordinary article about how a long-forgotten medical treatment, used in the former Soviet country of Georgia, could save us from the growing threat of untreatable, drug-resistant infections.
Join 15,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Codon Digest: Moore's Law
Codon
MARCH 26, 2023
Link A DNA tumor virus globally reprograms host 3D genome architecture to achieve immortal growth. Link DNA storage in thermoresponsive microcapsules for repeated random multiplexed data access. Link Semi-rational evolution of a recombinant DNA polymerase for modified nucleotide incorporation efficiency. Nucleic Acids Research.
Codon Digest: Ghana Approves A Better Malaria Vaccine
Codon
APRIL 23, 2023
Unfortunately, they can also trigger immune responses, and they are not super efficient at gene-editing some parts of the brain. These ribonucleoproteins also caused a lower immune response compared to the viruses, and are much easier to make in the lab. Nature Communications. Nature Communications. The New Yorker.
Codon Digest: Ghana Approves A Better Malaria Vaccine
Codon
APRIL 23, 2023
Unfortunately, they can also trigger immune responses, and they are not super efficient at gene-editing some parts of the brain. These ribonucleoproteins also caused a lower immune response compared to the viruses, and are much easier to make in the lab. Nature Communications. Nature Communications. The New Yorker.
Codon Digest: GPT-4 Controls a Robot
Codon
APRIL 16, 2023
Skin microbes can trigger strong immune responses. These microbes were engineered to express tumor antigens that could “elicit T cells that were licensed by the commensal immune program but specific for a tumor,” including both CD4+ and CD8+ T cells, according to the study. coli DNA using a Retro-Cascorder.
Let's personalize your content